This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genevive, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yuliya Katlinskaya: Innovator in Immunotherapy
Introduction
Yuliya Katlinskaya is a prominent inventor based in Brisbane, California. She has made significant contributions to the field of immunotherapy through her innovative research and development of therapeutic peptides. Her work focuses on utilizing microbially derived peptides and proteins to address various human diseases.
Latest Patents
Yuliya holds 1 patent for her invention titled "Microbially derived peptides and proteins for immunotherapy." This patent discloses therapeutic peptides and pharmaceutical compositions that have utility in treating a range of human diseases. The therapeutic peptides are particularly useful as immunotherapeutics, aimed at modulating regulatory and effector molecules of the mammalian immune system to mitigate disease.
Career Highlights
Yuliya has established herself as a key figure in her field, working with Genevive, Inc., where she continues to advance her research. Her dedication to innovation in immunotherapy has positioned her as a valuable contributor to the scientific community.
Collaborations
Yuliya collaborates with notable colleagues, including Helena Kiefel and Kareem L Graham, who share her commitment to advancing therapeutic solutions.
Conclusion
Yuliya Katlinskaya's work in developing microbially derived peptides for immunotherapy exemplifies her innovative spirit and dedication to improving human health. Her contributions are paving the way for new therapeutic approaches in the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile